Biogen will receive rights to commercialize zorevunersen outside the US, Canada, and Mexico, paying $165 million upfront and other milestone payments.
A recent John F. Kennedy Jr. Forum at the Institute of Politics (IOP) offered an opportunity for Harvard Kennedy School professors and IOP fellows to analyze what we have seen and what we might expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback